Navigation Links
CONRAD to host HIV symposium at 2nd Annual Antivirals Congress
Date:11/5/2012

Arlington, VA CONRAD HIV and microbicides experts will be featured at the 2nd Annual Antivirals Congress organized by Elsevier publications. This year's conference is being held on November 11-13 at the Boston Marriott Cambridge. Executive and Scientific Director Gustavo Doncel and Director of Product Development David Friend will discuss ex vivo models for testing topical antiviral microbicides and current antiretroviral based microbicide products.

Other speakers at the CONRAD symposium include Tom Hope from Northwestern University and Patrick Kiser from the University of Utah who will speak on defining the interaction of HIV and the mucosal barriers exposed during sexual transmission, and novel microbicide dosage forms to prevent HIV transmission, respectively.

What: CONRAD Symposium: The Use of Antiviral Agents to Prevent HIV Transmission

When and Where: Monday, November 12th 2:00-3:40PM Boston Marriott Cambridge

CONRAD, a not for profit scientific organization based in Arlington, Virginia, specializes in developing new contraceptive methods and products to prevent or reduce HIV and other sexually transmitted infections. Several products in the pipeline focus on multi-purpose prevention options which provide contraception as well as HIV and STI protection. CONRAD tested and developed tenofovir gel, the first drug to show proof of concept that a vaginal gel containing antiretrovirals can reduce HIV and HSV-2 infections when used before and after sex.

Tenofovir is a drug commonly used by those infected with HIV to prevent the virus from multiplying in the immune system. A clinical study of women in South Africa who used a vaginal gel containing tenofovir has shown that it is 40-54 percent effective in reducing sexual transmission when used before and after sex.

The Antiretrovirals Congress provides state-of-the-art reports for scientists, health professionals and non governmental authorities to accelerate progress in the development and application of antivirals. The Congress serves as an interface between different interest groups from academia, those in research and development, regulatory and governmental agencies, charities, and health and industry professionals.


'/>"/>

Contact: Annette Larkin
alarkin@conrad.org
703-772-6427
CONRAD
Source:Eurekalert

Related medicine news :

1. Triple negative breast cancer symposium highlights current advances
2. John Theurer Cancer Center hosting 8th Annual Neuro-Oncology Symposium
3. Kessler Foundation scientists present cognitive research findings at MS dual symposium
4. fiteBac™ SkinCare, LLC Participates in OSAP Symposium on Infection Control
5. International symposium on veterinary rehabilitation and physical therapy to be held in Vienna
6. Media alert: 24th EORTC - NCI - AACR Symposium Molecular Targets and Cancer Therapeutics
7. Symposium on sustainability to feature three new NJIT faculty
8. Key research from the 2012 Breast Cancer Symposium highlights treatment advances for early breast cancer
9. Leading stem cell scientists to focus on diabetes, eye diseases at Cedars-Sinai symposium
10. Penn Translational Medicine Institute to hold 7th Annual Symposium
11. International symposium will address non-Hodgkins lymphoma in the young
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... ... ... Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair ... hour by 2020 and then adjusting it yearly to increase at the same rate as ... the wage floor does not erode again, and make future increases more predictable. , The ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... ... Haute Living, is proud to recognize Dr. Barry M. Weintraub as a prominent ... “the most beautiful women in the world, and the most handsome men, look ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
(Date:6/23/2016)... June 23, 2016  MedSource announced today that ... e-clinical software solution of choice.  This latest decision ... value to their clients by offering a state-of-the-art ... relationship establishes nowEDC as the EDC platform of ... full-service clients.  "nowEDC has long been a preferred ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
Breaking Medicine Technology: